Transparency Market Research

Biobanking Market - Vast Patient Pool in Asia Pacific to Boost Growth Opportunities

Transparency Market Research Report Added "Biobanking Market" to its database.


Albany, NY -- (SBWIRE) -- 12/06/2016 -- The global biobanking market is the center of analysis of a recent market research report by Transparency Market Research, titled "Biobanking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013–2019." The report analyzes the market for key segments at regional and global fronts. Forecast regarding the growth prospects of segments and the overall market over the period between 2013 and 2019 is also given in the report.

The report examines the various factors expected to have a measurable impact on the overall development of the market over the said period. As such, aspects such as key driving and restraining factors, popular trends of past and present times, regulatory scenario, and competitive landscape are analyzed.

Read Full Report:

The report also presents a thorough overview of the core concepts related to biobanks. Biobanks, the repositories that store a variety of biological samples gathered for research purposes, play a crucial role in determining the success of research activities in the biomedical area. The data provided by biobanks is a result of analysis of a vast set of biological samples and can be used for purposes such as genetic trait identification and disease identification.

Biological samples in biobanks are categorized on the basis of genetic traits such as blood type, ethnicity, age, and gender. Moreover, biological samples are also classified based on environmental factors that are capable of having a mutational impact on the genes of the person being studied. The three key varieties of biobanks are commonly observed across the globe: population banks, tissue banks, and virtual biobanks.

With the rising prevalence of a variety of chronic diseases, the focus on biobanking has considerably increased in the past few years. The report states that the global biobanking market is also driven owing to the increased need to develop new drugs to efficiently treat the rapidly expanding patient pool of chronic diseases such as diabetes, cancer, and a variety of cardiovascular disorders. Biological samples and biomaterials are collected from biobanks by healthcare facilities such as academic centers, research laboratories, and hospitals. However, the growth of the global biobanking market is limited to a certain extent owing to the lack of high-quality biological samples.

Download exclusive Sample of this Report:

The report segments the global biobanking market into disease-based biobanks, population-based biobanks, and private sector biobanks. The market is further segmented on the basis of application into colorectal cancer, lung cancer, cardiovascular diseases, central nervous system disorders, and immunology-autoimmune diseases.

In terms of geography, the market has been segmented into regions such as North America, Europe, Asia Pacific, and Middle East and Africa. Presently, the North America biobanking market dominates owing to the presence of a large number of players in the region. The market in Asia Pacific, however, is expected to emerge as the leading regional market in terms of rate of expansion over the forecast period. The large population and the vast patient pool in the region will drive the market for biobanking in Asia Pacific.

Some of the key players operating in the global biobanking market are Thermo Fischer Scientific, Beckman Coulter Inc., Tecan AG, and New Brunswick Scientific Co. Inc.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453